# Mika Newton

> Mika Newton is the CEO of xCures Inc., an Oakland-based AI company transforming how cancer patients and oncologists navigate clinical data. With over two decades in life sciences and health technology, she leads a platform that automatically retrieves, structures, and surfaces medical records to support real-world evidence generation and precision oncology - helping patients find clinical trials and helping researchers capture regulatory-grade data at scale.

- **Role:** CEO at xCures Inc.
- **Organizations:** xCures Inc., Forbes Technology Council
- **Nationality:** American
- **Known for:** Led xCures to raise $12.69M in Series A funding led by Boehringer Ingelheim Venture Fund, Accepted into Forbes Technology Council (invitation-only community for world-class CIOs, CTOs, and technology executives), Built xCures into a 50+ person team with 12 oncologist medical advisors

## Career timeline

- **Early career** — Sales management and operations roles at Quintiles, Invitrogen, and Tripos
- **Mid career** — Vice President of Sales and Marketing at Archimedes
- **Mid career** — Senior Vice President, Client and Market Development at Evidera
- **Mid career** — General Manager of Clinical Development Services at diaDexus
- **Pre-xCures** — Chief Commercial Officer at Doctor Evidence, LLC
- **2018** — Joined xCures Inc. as CEO, leading transformation into AI-powered SaaS platform for precision oncology
- **2021** — Led Series A fundraise of $12.69M led by Boehringer Ingelheim Venture Fund
- **2021** — Accepted into Forbes Technology Council
- **2023** — Closed additional Convertible Note funding round
- **2024** — xCures activated as Qualified Health Information Network (QHIN) participant
- **2024** — Launched next-generation AI-powered platform; spoke at HLTH US 2024
- **2025** — Announced partnership with Atropos Health to advance AI for clinical decision-making

## Achievements

- Led xCures to raise $12.69M in Series A funding led by Boehringer Ingelheim Venture Fund
- Accepted into Forbes Technology Council (invitation-only community for world-class CIOs, CTOs, and technology executives)
- Built xCures into a 50+ person team with 12 oncologist medical advisors
- Established xCures as a QHIN-activated health data network participant
- Built XCELSIOR - an IRB-approved, patient-centric real-world data and outcomes registry
- Secured partnerships with NeoGenomics, Kidney Cancer Association, Cancer Commons, Atropos Health, and Huntsman Cancer Institute
- Speaker at PMWC Precision Medicine World Conference (2020, 2024), HLTH US 2024, and ATA Nexus Conference

## Latest updates

- **2025-01** — xCures and Atropos Health announced a partnership to advance AI for clinical decision-making and patient outcomes
- **2024-12** — Partnership with NeoGenomics for clinical data access through HIE and QHIN integration
- **2024-10** — xCures activated as a Qualified Health Information Network (QHIN) participant
- **2024-10** — Launch of next-generation AI-powered platform unveiled at HLTH US 2024
- **2024-05** — Partnership with Kidney Cancer Association for enhanced patient data control
- **2023-12** — Closed Convertible Note funding round

## Links

- Website: https://xcures.com
- LinkedIn: http://www.linkedin.com/in/mikanewton
- Twitter/X: https://twitter.com/mika_newton
- Facebook: https://www.facebook.com/xcures.platform/

---

Profile page: https://yespress.io/mika-newton
Published by YesPress — https://yespress.io
Last updated: 2026-05-16